Literature DB >> 10921689

Ten-year experience with Mersilene-reinforced sternal wound closure.

M M Puc1, C H Antinori, D T Villanueva, M Tarnoff, J A Heim.   

Abstract

BACKGROUND: We were interested in reviewing our experience with Mersilene-reinforced sternal wound closure to evaluate its overall morbidity and its impact on patient management.
METHODS: We reviewed our experience with 1,039 patients undergoing median sternotomy with Mersilene-reinforced sternal wound closure over the past 10 years. Major wound complications, which were categorized into two groups, required in-hospital management and operative intervention. Group 1 had a sternal dehiscence alone. Group II had a major sternal infection or mediastinitis.
RESULTS: The incidence of wound morbidity was 2.4% (n = 25). There were 6 (0.58%) sternal dehiscences (Group I) and 19 (1.8%) sternal wound infections (Group II). Patients taken to the operating room for repair of their sternal dehiscence or sternal infection were noted to have two completely intact sternal halves.
CONCLUSIONS: While wound related morbidity with Mersilene tape closure is equivalent to the historical results of conventional wire closure, dehiscence occurs in a more controlled fashion with less bony destruction. The reduction in tissue damage associated with sternal wound dehiscence and sternal infection after Mersilene-reinforced sternal wound closure makes treatment of these potentially devastating complications easier and more efficient.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10921689     DOI: 10.1016/s0003-4975(00)01424-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  1 in total

1.  Intracutaneous versus transcutaneous suture techniques: comparison of sternal wound infection rates in open-heart surgery patients.

Authors:  Ozalp Karabay; Emel Fermanci; Erdem Silistreli; Koray Aykut; Ismail Yurekli; Hudai Catalyurek; Unal Acikel
Journal:  Tex Heart Inst J       Date:  2005
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.